WO2018006618A1 - Self-hardening degradable bioactive bone repair material paste and use thereof - Google Patents

Self-hardening degradable bioactive bone repair material paste and use thereof Download PDF

Info

Publication number
WO2018006618A1
WO2018006618A1 PCT/CN2017/076980 CN2017076980W WO2018006618A1 WO 2018006618 A1 WO2018006618 A1 WO 2018006618A1 CN 2017076980 W CN2017076980 W CN 2017076980W WO 2018006618 A1 WO2018006618 A1 WO 2018006618A1
Authority
WO
WIPO (PCT)
Prior art keywords
self
bioactive
repair material
bone repair
cure
Prior art date
Application number
PCT/CN2017/076980
Other languages
French (fr)
Chinese (zh)
Inventor
钟吉品
Original Assignee
盐城倍尔生生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 盐城倍尔生生物科技有限公司 filed Critical 盐城倍尔生生物科技有限公司
Publication of WO2018006618A1 publication Critical patent/WO2018006618A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/10Ceramics or glasses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/38Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Definitions

  • Vertebroplasty surgery in China from less than 20,000 operations per year from 2010 to 120,000 operations in 2015, is expected to increase by 15% per year. Vertebroplasty is the pain caused by the fracture of the vertebral body of the victim patient due to various reasons, and the normal operation of the vertebral body. The collapsed vertebral body must be propped up by surgery to slowly restore the spine to normal work and relieve the patient's pain.
  • bone cement is used to fix artificial knees and hip handles, and there are no less than one million operations in China each year.
  • bio-inert bone cement is used for filling the collapsed vertebral body or filling the defect in the international and domestic countries for many years.
  • the chemical name is polymethyl methacrylate. , codenamed PMMA.
  • Inert bone cement can be quickly formulated into the vertebral body by initial blending into a paste, and has strength to support and fix. These operations are very mature.
  • vertebroplasty is a typical modern minimally invasive surgery. There is no need to open a knife. A dose of paste is injected into the collapse of the vertebral body fracture.
  • inert bone cement is required to fix artificial knee and hip joint replacements in most knee hip replacement surgery. Because inert bone cement does not form a bone bond with bone tissue, generally in a decade or so If the fixation will be loose and the replacement of the joint body needs to be repaired again, it will produce a larger defect.
  • the ideal bone cement repair material should be a paste dosage form, which can be pushed to the best; it can establish a certain mechanical strength by solidification in a reasonable time; based on the clinical application in orthopedic surgery, within 20 minutes after 10 minutes Coagulation is ideal; thus, the surgeon is given time to perform surgical preparation and operation, and can be rapidly solidified after the bone cement repair material is placed in the filled defect; the bone cement repair material is placed in the filled defect After a certain period of time, such as 2 weeks to achieve a compressive strength of at least 20MPa; it is particularly important that the ideal bone cement repair material must have biological activity and osteoconductivity, and can slowly degrade, such as 2 to 3 years completely Degradation, can not degrade too fast, otherwise it can not reach the supporting effect; it can not become a hard stone without degradation; while slowly degrading, the material will guide the growth of the body bone by biological activity and osteoconductivity, and finally, the bone cement repair material When fully degraded, it is completely replaced by the growing body bone. So far, there is no such
  • Bioactive glass materials are the most biologically active materials in synthetic bone repair materials.
  • the artificial bone repair products developed by bioactive glass materials have been successfully applied in orthopedic clinics in the world and in China for more than 20 years. It is currently the only product approved by the US FDA with Osteostmulation, which promotes the proliferation and growth of bone cells and activates gene expression of bone cells, thus accelerating the formation of new bone.
  • bioactive glass products are in the form of granules, blocks and pastes, but they do not solidify to withstand gravity loads. When the bioactive glass of less than 50 ⁇ m is mixed with the liquid, the binding energy of the Si—O bond and the water hydrogen bond is solidified by the surface reaction, but the solidification strength is very weak.
  • Tricalcium silicate is the main chemical component of the famous Portland cement. It is characterized by its ability to solidify into a material with high strength and can be used as a building material. However, the disadvantage is that the solidification time is longer, and it usually takes more than 1 hour to solidify. This is not practical in the clinic. But the structure remains stable over a longer period of time. High mechanical strength is required as a load-bearing bone repair material such as for vertebroplasty, knee and hip replacement surgery, and certain fracture repairs.
  • the main technical problem to be solved by the present invention is to provide a bioactive paste bone repairing material and application thereof, which adopts a bioactive glass-calcium sulfate hemihydrate-tricalcium silicate system, which has a more ideal self-curing absorption.
  • sexuality can be used as an alternative material for bone repair in vertebral body shaping surgery, knee hip replacement surgery and other fracture operations.
  • the bioactive glass is a bioactive glass having a composition of 45S5.
  • the inorganic salt solution is a carbonate solution, a calcium chloride solution, One or more of the phosphate solutions.
  • the self-cure degradable bioactive paste bone repair material has a setting time of 10-20 minutes; the self-cure degradable bioactive paste bone repair material is in a biological environment. The mechanical strength is gradually enhanced; the self-cure degradable bioactive plaster bone repair material has a slow degradability.
  • the self-cure degradable bioactive cream bone repair material is applied in a bone defect filling procedure.
  • the self-cure degradable bioactive plaster bone repair material is applied in orthopedic vertebral body shaping surgery and knee hip joint replacement surgery.
  • the self-cure degradable bioactive paste bone repair material can be directly conditioned with the antibiotic when used, while maintaining the pharmacodynamic effect without affecting the setting time and strength; preferably,
  • the antibiotic is a gentamicin liquid.
  • the present invention uses an aqueous solution to reconcile the ternary mixture, and can be directly used in an aqueous solution of an antibiotic solution during use, which is more convenient. The storage and preservation of the drug and the medicinal properties do not affect the time and intensity of the coagulation reaction.
  • Figure 1 is a schematic illustration of a pushable shot of the paste of the present invention
  • 2 is a reaction of the present invention after self-curing in a human body solution for 1 day, 3 days, and 7 days;
  • Figure 3 is a graph showing the results of the compressive strength of the paste of the present invention as a function of reaction time
  • Figure 4 is a model diagram of the paste of the present invention for animal experiments
  • Figure 5 is a histological diagram of the plaster of the present invention implanted into the rabbit tibia defect for 3 months;
  • Figure 6 is a view showing the osseointegration rate of the paste implanted into the rabbit tibia after the paste of the present invention, that is, the material and the bone tissue form bone
  • a self-cure degradable bioactive ointment bone repair material including bioactive glass, calcium sulfate hemihydrate, tricalcium silicate, and a solution.
  • the self-cure degradable bioactive paste bone repair material that is, the bioactive glass-calcium sulfate hemihydrate-tricalcium silicate ternary system solidification reaction mechanism is as follows:
  • the surface of the tricalcium silicate particles first dissolves when it encounters water. At this time, calcium and silicon ions are accumulated in the water between the voids of the particles to saturation, and a new phase deposition occurs.
  • the sediment is Calcium-Silicate-Hydrate gel (or CSH), and the reaction formula is: 2 Ca 3 SiO 5 +7 H 2 O ⁇ 3 CaO ⁇ 2 SiO 2 ⁇ 4 H 2 O+3 Ca (OH) 2 .
  • This process is called the hydration-deposition reaction process.
  • the decrease in the ion concentration in the water after deposition causes the hydrolysis to proceed and then the deposition will occur again, so that the hydration-deposition reaction proceeds continuously.
  • the hydration-deposition reaction in reactions (2) and (3) is a dynamic continuous process, the reaction is continued until the moisture content is reduced, and the new deposition phase fills the interparticle voids so that the density increases and the strength increases to achieve solidification.
  • the basic reaction principle of self-curing solidification The difference is that the calcium sulfate hemihydrate reacts quickly and reaches the final setting state in 7 minutes.
  • the tricalcium silicate reaction is slower and usually takes more than 60 minutes to reach final setting.
  • the reaction (1) that is, the release of calcium and silicon ions on the surface of the bioactive glass particles will greatly accelerate the speed of the reaction (2) and the reaction (3), that is, Accelerate the formation of the hydrated calcium silicate gel phase and the calcium sulfate dihydrate crystal phase.
  • the formation of these two new phases occupies the particle gap to increase the density of the material, on the other hand, the new phase formed at the same time is intertwined with the original bioactive glass particles, the tricalcium silicate particles and the calcium sulfate hemihydrate particles. Material strength. This causes the ternary material to solidify faster and the curing time becomes shorter. This feature makes the ternary system more widely applicable.
  • the experimental method of the present invention is to thoroughly mix the three materials in different proportions and the bioactive glass according to different particle sizes, and each mixture and the solution are fully tempered for 1 minute at a liquid-solid mass ratio of 0.40-0.7 ml/g, that is, Get the pushable paste we have described.
  • the solution used in the present invention is one of a solution of physiological saline, deionized water, inorganic salts (carbonate, calcium chloride, phosphate, etc.).
  • the initial setting time is defined as the time required for the Vicat instrument needle (280g, 1.13mm) to fall vertically to the paste contained in the small tube at a depth of 5 ⁇ 1mm;
  • the final setting time is defined as the Vicat needle (350g, 2.0) Mm) The time required for the mark to be placed in the small tube to be invisible on the surface.
  • the blending solution is deionized water, the blending ratio is 1g: 0.5ml, and the solidification condition is in the air:
  • the blending solution is deionized water and the solidification conditions are in an aqueous solution:
  • the blending solution is deionized water and the solidification conditions are in the air:
  • the blending solution is deionized water and the solidification conditions are in an aqueous solution:
  • the blending solution is a CaCl 2 inorganic salt solution, and the solidification conditions are in an aqueous solution:
  • Biological activity test method self-curing bioactive material is blended according to the ratio, the blending solution is deionized water, the blending ratio is 0.5 ml/g, and the blending time is 60 seconds.
  • the prepared paste is then used in a mold: 6-mm diameter x 2-mm height, and solidified into a wafer.
  • the number of samples is 3.
  • the reaction was 1 day, 3 days and 7 days.
  • the reaction samples were subjected to FTIR infrared reflectance spectroscopy for surface testing. The appearance of the reflection peaks of 574 cm -1 and 608 cm -1 will indicate the formation of hydroxyapatite, indicating that the material is biologically active.
  • the test results are shown in Figure 2.
  • Embodiment 3 is a diagrammatic representation of Embodiment 3
  • the new self-curing bioactive product sample is determined by SBF quasi-human solution soaking reaction for different time to determine the compressive strength change.
  • the self-curing bioactive material is blended according to the ratio, the blending solution is deionized water, the blending ratio is 0.5 ml/g, and the blending time is 60 seconds.
  • the prepared paste is then used in a mold: 6-mm diameter x 12-mm height, and solidified into a cylinder. The number of samples is 30.
  • the reaction was at 6 time points, each time point was a group, the samples were divided into 6 groups, and 5 samples were tested in each group.
  • the six time points are: 1 hour, 2 hours, 8 hours, 1 day, 3 days, and 7 days.
  • the statistical results of each set of test results were averaged and the positive and negative differences were calculated.
  • the results of compressive strength as a function of reaction time are shown in the following table and in Figure 3.
  • Embodiment 4 is a diagrammatic representation of Embodiment 4:
  • FIG. 6 shows the percentage of the bone binding rate after material implantation, that is, the area where the material forms bone binding with the bone tissue. This indicates that the material surface and bone tissue exhibit a good bone bond.
  • the usual bioactive bone repair materials show significant degradation at 3 months.
  • the optimum composition of the present invention No. 18 showed degradation on the surface at 3 months but the material substantially retained its shape, indicating a very slow rate of degradation. This is a paste which can be solidified and can bear the load and is biologically active, which will slowly degrade, guide the formation of bone tissue, and finally be replaced by the body bone tissue, which is the most ideal bone repair product.
  • the invention discloses a pushable self-curing degradable bioactive paste bone repairing material formed by a bioactive glass-calcium sulfate hemihydrate-tricalcium silicate ternary system, which can be used instead of the commonly used inert bone cement.
  • a bioactive glass-calcium sulfate hemihydrate-tricalcium silicate ternary system which can be used instead of the commonly used inert bone cement.
  • This new generation of bone cement repair material can establish a certain mechanical strength by solidification in a reasonable time. Of particular importance is the fact that this new generation of bone cement repair materials accelerates clotting time due to the introduction of bioactive glass, enhancing bioactivity and osteoconductivity as well as slow degradation.
  • the material will guide the growth of the body bone by biological activity and osteoconductivity, and finally, the bone cement repair material will drop completely.
  • the solution is solved, it is completely replaced by the growing body bone.
  • antibiotics such as gentamicin liquid, with no significant effect on solidification time and mechanical strength.
  • the antibiotic is introduced into the system for sustained release to prevent infection at the wound site.
  • a more desirable self-curing self-cure absorbable plaster cement repair material can be used as an alternative to bone repair for vertebral body shaping surgery, knee hip replacement surgery, and other fracture operations.

Abstract

Provided is a self-hardening degradable bioactive bone repair material in the form of a paste, comprising: a bioactive glass material, calcium sulfate hemihydrate, tricalcium silicate and a blending liquid. The bone repair material can substitute for polymethylmethacrylate (PMMA) and is applied in orthopedic procedures including vertebroplasty, knee and hip replacement procedures and other procedures for filling bone fractures and defects. The bone repair material can be directly mixed with an antibiotic.

Description

自固化可降解的生物活性膏剂骨修复材料及应用Self-curing degradable bioactive paste bone repair material and application 技术领域Technical field
本发明涉及医药生物材料领域,特别是涉及一种自固化可降解的生物活性膏剂骨修复材料及应用。The invention relates to the field of medical biomaterials, in particular to a self-cure degradable bioactive paste bone repairing material and application.
背景技术Background technique
随着生物科技的发展,医疗器械产业特别是骨科医疗器械技术和产业发展兴旺。目前,在骨科椎体成型手术、膝髋关节置换手术中,都需要用骨水泥来起到力学支撑或置换体的固定。椎体成型手术在中国从2010年前每年不到2万台手术到2015年12万台手术,预期每年会有15%的增长。椎体成型术为受害病人椎体因各种原因骨折塌陷导致疼痛以及不能正常行动,必须通过手术将塌陷的椎体撑起,使脊椎慢慢恢复正常工作,减轻病人痛苦。在膝髋关节置换手术中,骨水泥用来固定人工膝盖和髋柄,每年在中国有不低于百万台的手术。在这些手术中,多年来在国际国内填充到塌陷的椎体中或填充在缺损中来固定人工膝盖和髋柄用的是生物惰性骨水泥,化学名称为聚甲基丙烯酸甲酯(polymethyl methacrylate),代号PMMA。惰性骨水泥能在初期调配成膏体推注入椎体能迅速凝固,并具有强度起到支撑和固定作用。这些手术已很成熟。特别是椎体成型术是比较典型的现代微创手术,不用开刀,一剂膏体推注到椎体骨折塌陷处,数小时内病人可离开医院回家疗养恢复。但最大问题是惰性骨水泥不降解,与骨组织也不融合,几年后,如同一块硬石头存在在病人人体中,对周围组织会有破坏作用,存在椎体再次塌陷破裂的可能。基于这一缺点,骨科大夫通常会对年轻或中年的椎体骨折的病人比较慎重,会尽量避免使用惰性骨水泥而采取其它复杂手术办法来避免将来由惰性骨水泥带来的问题。With the development of biotechnology, the medical device industry, especially orthopedic medical device technology and industry, is booming. At present, in orthopedic vertebral body formation surgery and knee hip joint replacement surgery, bone cement is required to fix the mechanical support or the replacement body. Vertebroplasty surgery in China from less than 20,000 operations per year from 2010 to 120,000 operations in 2015, is expected to increase by 15% per year. Vertebroplasty is the pain caused by the fracture of the vertebral body of the victim patient due to various reasons, and the normal operation of the vertebral body. The collapsed vertebral body must be propped up by surgery to slowly restore the spine to normal work and relieve the patient's pain. In knee and hip replacement surgery, bone cement is used to fix artificial knees and hip handles, and there are no less than one million operations in China each year. In these procedures, bio-inert bone cement is used for filling the collapsed vertebral body or filling the defect in the international and domestic countries for many years. The chemical name is polymethyl methacrylate. , codenamed PMMA. Inert bone cement can be quickly formulated into the vertebral body by initial blending into a paste, and has strength to support and fix. These operations are very mature. In particular, vertebroplasty is a typical modern minimally invasive surgery. There is no need to open a knife. A dose of paste is injected into the collapse of the vertebral body fracture. Within a few hours, the patient can leave the hospital and go to the hospital to recover. But the biggest problem is that the inert bone cement does not degrade and does not fuse with the bone tissue. After a few years, like a hard stone exists in the patient's body, it will have a destructive effect on the surrounding tissue, and there is a possibility that the vertebral body will collapse again. Based on this shortcoming, orthopedic doctors are usually more cautious about young or middle-aged patients with vertebral fractures. They will try to avoid using inert bone cement and other complicated surgical procedures to avoid future problems caused by inert bone cement.
目前,在大部分膝髋关节置换手术中需要用这一惰性骨水泥来固定人工膝和髋关节置换体。由于惰性骨水泥与骨组织不形成骨性结合,一般在十年左右 固定会出现松动而置换的关节体需要再行手术翻修,会产生更大缺损。At present, this inert bone cement is required to fix artificial knee and hip joint replacements in most knee hip replacement surgery. Because inert bone cement does not form a bone bond with bone tissue, generally in a decade or so If the fixation will be loose and the replacement of the joint body needs to be repaired again, it will produce a larger defect.
理想的骨水泥修复材料应为膏体剂型,可推注为最佳;能在合理的时间内凝固逐渐建立起一定的力学强度;基于在骨科手术中的临床应用,在10分钟后20分钟内凝固比较理想;这样,给予手术大夫有一定时间进行手术准备和操作,又能在骨水泥修复材料被放置在所填充的缺损处后迅速凝固成形;骨水泥修复材料被放置在所填充的缺损处后能在一定时间内,如2星期内达到至少20MPa的抗压强度;特别重要的是理想的骨水泥修复材料必须具有生物活性及骨传导性,又能缓慢降解,如2到3年时间完全降解,不能降解太快,否则未能达到支撑作用;也不能不降解将会成为一块硬石头;缓慢降解的同时,材料由生物活性及骨传导性会引导本体骨生长,最终,骨水泥修复材料完全降解时,由生长的本体骨完全取而代之。到目前为止,在椎体成型术、膝髋关节置换手术中和其它骨科手术中还没有这样一个理想的材料和产品来取代传统惰性骨水泥。The ideal bone cement repair material should be a paste dosage form, which can be pushed to the best; it can establish a certain mechanical strength by solidification in a reasonable time; based on the clinical application in orthopedic surgery, within 20 minutes after 10 minutes Coagulation is ideal; thus, the surgeon is given time to perform surgical preparation and operation, and can be rapidly solidified after the bone cement repair material is placed in the filled defect; the bone cement repair material is placed in the filled defect After a certain period of time, such as 2 weeks to achieve a compressive strength of at least 20MPa; it is particularly important that the ideal bone cement repair material must have biological activity and osteoconductivity, and can slowly degrade, such as 2 to 3 years completely Degradation, can not degrade too fast, otherwise it can not reach the supporting effect; it can not become a hard stone without degradation; while slowly degrading, the material will guide the growth of the body bone by biological activity and osteoconductivity, and finally, the bone cement repair material When fully degraded, it is completely replaced by the growing body bone. So far, there is no such ideal material and product to replace traditional inert bone cement in vertebroplasty, knee hip replacement surgery and other orthopedic surgery.
生物活性玻璃材料是目前人工合成的骨修复材料中生物活性最快的材料。生物活性玻璃材料开发出的人工骨修复产品已在全球以及中国在骨科临床上成功应用20年多。是目前唯一被美国FDA认可的具有骨激发(Osteostmulation)特性的产品,即能促进骨细胞的繁衍和增长,活化骨细胞的基因表达,这样加速新骨的形成。目前在国际上生物活性玻璃产品形式为颗粒、块体以及膏剂型,但都不会凝固来承受重力负荷。当小于50μm的生物活性玻璃与液体混合时,由其表面反应发生Si-O键以及水氢键的结合能发生凝固,但凝固强度十分微弱。Bioactive glass materials are the most biologically active materials in synthetic bone repair materials. The artificial bone repair products developed by bioactive glass materials have been successfully applied in orthopedic clinics in the world and in China for more than 20 years. It is currently the only product approved by the US FDA with Osteostmulation, which promotes the proliferation and growth of bone cells and activates gene expression of bone cells, thus accelerating the formation of new bone. Currently, bioactive glass products are in the form of granules, blocks and pastes, but they do not solidify to withstand gravity loads. When the bioactive glass of less than 50 μm is mixed with the liquid, the binding energy of the Si—O bond and the water hydrogen bond is solidified by the surface reaction, but the solidification strength is very weak.
硫酸钙也是作为骨修复常用的材料。硫酸钙与液体混合在几分钟内凝固,但强度不太理想。最主要不足之处是硫酸钙降解速度太快,可能在3个月内绝大部分降解而失去了在塌陷缺损处的支撑作用。Calcium sulfate is also commonly used as a material for bone repair. Calcium sulphate is mixed with the liquid to solidify in a few minutes, but the strength is not ideal. The main disadvantage is that the degradation rate of calcium sulfate is too fast, and most of the degradation may be lost within 3 months and the support at the collapse defect is lost.
硅酸三钙是著名的波特兰水泥的主要化学成分。其特点是可凝固成具有较高强度的材料,能成为建筑材料被使用。但缺点是凝固时间较长,一般需要1小时以上才能凝固。这在临床上是不实用的。但在较长的时间结构稳定保持较 高的力学强度是作为可负载负荷的骨修复材料如用于椎体成形手术、膝髋关节置换手术以及某些骨折修复是比较需要的。Tricalcium silicate is the main chemical component of the famous Portland cement. It is characterized by its ability to solidify into a material with high strength and can be used as a building material. However, the disadvantage is that the solidification time is longer, and it usually takes more than 1 hour to solidify. This is not practical in the clinic. But the structure remains stable over a longer period of time. High mechanical strength is required as a load-bearing bone repair material such as for vertebroplasty, knee and hip replacement surgery, and certain fracture repairs.
发明内容Summary of the invention
本发明主要解决的技术问题是提供一种生物活性膏剂骨修复材料及应用,采用生物活性玻璃-半水硫酸钙-硅酸三钙三元系统,具有更为理想的可推注自固化可吸收性,能作为骨修复替代材料用于椎体成型手术、膝髋关节置换手术以及其它一些骨折手术中的应用。The main technical problem to be solved by the present invention is to provide a bioactive paste bone repairing material and application thereof, which adopts a bioactive glass-calcium sulfate hemihydrate-tricalcium silicate system, which has a more ideal self-curing absorption. Sexuality can be used as an alternative material for bone repair in vertebral body shaping surgery, knee hip replacement surgery and other fracture operations.
为解决上述技术问题,本发明采用的一个技术方案是:提供一种自固化可降解的生物活性膏剂骨修复材料,包括混合固体材料和液相,所述混合固体材料包括生物活性玻璃、半水硫酸钙和硅酸三钙,所述液相包括调和液。In order to solve the above technical problem, the present invention adopts a technical solution to provide a self-curing degradable bioactive paste bone repair material, including a mixed solid material and a liquid phase, the mixed solid material including bioactive glass and semi-aqueous water. Calcium sulfate and tricalcium silicate, the liquid phase comprising a blending liquid.
在本发明一个较佳实施例中,所述混合固体材料的组成包括:以重量百分比计,生物活性玻璃15%-30%、半水硫酸钙30%-45%、硅酸三钙30%-40%;所述混合固体材料与所述液相的调和比为1g:0.3ml-1g:0.8ml;所述生物活性玻璃的粒径小于等于100μm,所述半水硫酸钙的粒径小于等于100μm,所述硅酸三钙的粒径小于等于100μm。In a preferred embodiment of the present invention, the composition of the mixed solid material comprises: 15%-30% by weight of bioactive glass, 30%-45% of calcium sulfate hemihydrate, and 30% of tricalcium silicate. 40%; the blending ratio of the mixed solid material to the liquid phase is 1 g: 0.3 ml-1 g: 0.8 ml; the particle diameter of the bioactive glass is 100 μm or less, and the particle size of the calcium sulfate hemihydrate is less than or equal to 100 μm, the particle size of the tricalcium silicate is 100 μm or less.
在本发明一个较佳实施例中,所述混合固体材料的组成包括:以重量百分比计,生物活性玻璃27%、半水硫酸钙41.5%、硅酸三钙31.5%;所述混合固体材料与所述液相的调和比为1g:0.5ml。In a preferred embodiment of the present invention, the composition of the mixed solid material comprises: 27% by weight of bioactive glass, 41.5% of calcium sulfate hemihydrate, and 31.5% of tricalcium silicate; the mixed solid material and The blending ratio of the liquid phase was 1 g: 0.5 ml.
在本发明一个较佳实施例中,所述生物活性玻璃是组成为45S5的生物活性玻璃。In a preferred embodiment of the invention, the bioactive glass is a bioactive glass having a composition of 45S5.
在本发明一个较佳实施例中,所述调和液为生理盐水、去离子水、无机盐溶液中的一种或多种。In a preferred embodiment of the invention, the solution is one or more of physiological saline, deionized water, and inorganic salt solution.
在本发明一个较佳实施例中,所述无机盐溶液为碳酸盐溶液、氯化钙溶液、 磷酸盐溶液中的一种或多种。In a preferred embodiment of the present invention, the inorganic salt solution is a carbonate solution, a calcium chloride solution, One or more of the phosphate solutions.
在本发明一个较佳实施例中,所述自固化可降解的生物活性膏剂骨修复材料的凝固时间为10-20分钟;所述自固化可降解的生物活性膏剂骨修复材料在生物环境中的力学强度是逐渐增强的;所述自固化可降解的生物活性膏剂骨修复材料具有缓慢降解性。In a preferred embodiment of the present invention, the self-cure degradable bioactive paste bone repair material has a setting time of 10-20 minutes; the self-cure degradable bioactive paste bone repair material is in a biological environment. The mechanical strength is gradually enhanced; the self-cure degradable bioactive plaster bone repair material has a slow degradability.
在本发明一个较佳实施例中,所述自固化可降解的生物活性膏剂骨修复材料在骨缺损填充手术中进行应用。In a preferred embodiment of the invention, the self-cure degradable bioactive cream bone repair material is applied in a bone defect filling procedure.
在本发明一个较佳实施例中,所述自固化可降解的生物活性膏剂骨修复材料在骨科椎体成型手术、膝髋关节置换手术中进行应用。In a preferred embodiment of the present invention, the self-cure degradable bioactive plaster bone repair material is applied in orthopedic vertebral body shaping surgery and knee hip joint replacement surgery.
在本发明一个较佳实施例中,所述自固化可降解的生物活性膏剂骨修复材料在使用时能直接与抗菌素调和,同时保持了药效性又不影响凝固时间和强度;优选地,所述抗菌素为庆大霉素液体。In a preferred embodiment of the present invention, the self-cure degradable bioactive paste bone repair material can be directly conditioned with the antibiotic when used, while maintaining the pharmacodynamic effect without affecting the setting time and strength; preferably, The antibiotic is a gentamicin liquid.
本发明的有益效果是:The beneficial effects of the invention are:
1、三元混合体组成由于生物活性玻璃的存在增加的生物活性即作为骨修复材料的成骨性。1. Ternary Mixture Composition The increased biological activity due to the presence of bioactive glass is the osteogenicity of the bone repair material.
2、生物活性玻璃的引入加快了体系组成的凝固时间。2. The introduction of bioactive glass accelerates the solidification time of the system composition.
3、由于体系组成中硅酸三钙的存在,在液体环境中,硅酸三钙会继续反应至数月,并会使得凝固体的强度不断增加。最后为负荷应用的骨修复材料,这一特性至关重要。3. Due to the presence of tricalcium silicate in the system composition, in the liquid environment, the tricalcium silicate will continue to react for several months, and the strength of the solidified body will continue to increase. This feature is critical to the final bone repair material for load applications.
4、本世纪初,大量临床证明抗菌素引入骨水泥中能在手术初期起抗感染作用,手术后的翻修率显著减少。由于惰性骨水泥用一种有机物溶液调和,抗菌素必须要预先加入粉体中,既影响其药效性,又影响固化时间。而本发明使用水溶液调和三元混合体,可直接在使用时使用抗菌素水溶液调和,能较方便理 想的储存和保存药物和药性又不影响凝固反应时间和强度。4. At the beginning of this century, a large number of clinically proven antibiotics were introduced into bone cement to prevent infection in the early stage of surgery, and the rate of revision after surgery was significantly reduced. Since the inert bone cement is blended with an organic solution, the antibiotic must be added to the powder in advance, which affects both the efficacy and the curing time. However, the present invention uses an aqueous solution to reconcile the ternary mixture, and can be directly used in an aqueous solution of an antibiotic solution during use, which is more convenient. The storage and preservation of the drug and the medicinal properties do not affect the time and intensity of the coagulation reaction.
附图说明DRAWINGS
为了更清楚地说明本发明实施例中的技术方案,下面将对实施例描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其它的附图,其中:In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings used in the description of the embodiments will be briefly described below. It is obvious that the drawings in the following description are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained according to these drawings without any creative work, wherein:
图1是本发明所述膏剂的可推注示意图;Figure 1 is a schematic illustration of a pushable shot of the paste of the present invention;
图2是本发明所述膏剂自固化后在拟人体溶液中反应1天、3天、7天后的2 is a reaction of the present invention after self-curing in a human body solution for 1 day, 3 days, and 7 days;
红外光谱图;Infrared spectra;
图3是本发明所述膏剂的抗压强度随反应时间变化结果图;Figure 3 is a graph showing the results of the compressive strength of the paste of the present invention as a function of reaction time;
图4是本发明所述膏剂进行动物实验的模型图;Figure 4 is a model diagram of the paste of the present invention for animal experiments;
图5是本发明所述膏体植入兔髁骨缺损3个月后组织学情况图;Figure 5 is a histological diagram of the plaster of the present invention implanted into the rabbit tibia defect for 3 months;
图6是本发明所述膏体植入兔髁骨缺损后骨结合率即材料与骨组织形成骨Figure 6 is a view showing the osseointegration rate of the paste implanted into the rabbit tibia after the paste of the present invention, that is, the material and the bone tissue form bone
性结合的面积百分比图。A graph of the area percentage of sexual association.
具体实施方式detailed description
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below. It is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments obtained by a person of ordinary skill in the art based on the embodiments of the present invention without creative efforts are within the scope of the present invention.
提供一种自固化可降解的生物活性膏剂骨修复材料,包括生物活性玻璃、半水硫酸钙、硅酸三钙和调和液。A self-cure degradable bioactive ointment bone repair material is provided, including bioactive glass, calcium sulfate hemihydrate, tricalcium silicate, and a solution.
所述自固化可降解的生物活性膏剂骨修复材料,即生物活性玻璃-半水硫酸钙-硅酸三钙三元系统凝固反应机理如下: The self-cure degradable bioactive paste bone repair material, that is, the bioactive glass-calcium sulfate hemihydrate-tricalcium silicate ternary system solidification reaction mechanism is as follows:
当三元混合物与水混合调匀成膏体后,将有三个反应进行:When the ternary mixture is mixed with water and mixed into a paste, three reactions will be carried out:
(1)生物活性玻璃颗粒表面遇水后迅速发生表面反应释放出钙和硅离子。(1) The surface of the bioactive glass particles rapidly reacts with water to release calcium and silicon ions.
(2)硅酸三钙颗粒表面遇水后首先发生溶解。这时,颗粒空隙间的水中积聚钙硅离子到饱和,出现新的相的沉积。沉积物为水合硅酸钙凝胶(Calcium-Silicate-Hydrate gel,or C-S-H),反应式为:2 Ca3SiO5+7 H2O→3 CaO·2 SiO2·4 H2O+3 Ca(OH)2。这一过程称为水化-沉积反应过程。沉积后水中离子浓度降低使得水解继续进行然后沉积又将出现,这样水化-沉积反应连续进行。(2) The surface of the tricalcium silicate particles first dissolves when it encounters water. At this time, calcium and silicon ions are accumulated in the water between the voids of the particles to saturation, and a new phase deposition occurs. The sediment is Calcium-Silicate-Hydrate gel (or CSH), and the reaction formula is: 2 Ca 3 SiO 5 +7 H 2 O→3 CaO·2 SiO 2 ·4 H 2 O+3 Ca (OH) 2 . This process is called the hydration-deposition reaction process. The decrease in the ion concentration in the water after deposition causes the hydrolysis to proceed and then the deposition will occur again, so that the hydration-deposition reaction proceeds continuously.
(3)半水硫酸钙颗粒遇水后的反应与硅酸三钙相似,只不过被认为反应更迅速。反应式为:CaSO4·1/2H2O+3/2H2O→CaSO4·2H2O。首先水化反应离子产物会迅速在周围表面和颗粒空隙中沉淀析晶为稳定相-二水硫酸钙。(3) The reaction of calcium sulphate hemihydrate particles after water contact is similar to that of tricalcium silicate, but it is considered to be more rapid. The reaction formula is: CaSO 4 · 1/2H 2 O+3/2H 2 O→CaSO 4 ·2H 2 O. First, the hydration reaction ion product will rapidly precipitate and crystallize into the stable phase-calcium sulfate dihydrate in the surrounding surface and the voids of the particles.
反应(2)和(3)中的水化-沉积反应是一个动态连续过程,反应直至水分含量降低,新的沉积相填充颗粒间空隙使得密度增加强度增高以达到凝固,这是这两个材料自固化凝固的基本反应原理。不同之处是半水硫酸钙反应迅速,7分钟能达到终凝状态。而硅酸三钙反应较慢,通常需要60分钟以上达到终凝。The hydration-deposition reaction in reactions (2) and (3) is a dynamic continuous process, the reaction is continued until the moisture content is reduced, and the new deposition phase fills the interparticle voids so that the density increases and the strength increases to achieve solidification. The basic reaction principle of self-curing solidification. The difference is that the calcium sulfate hemihydrate reacts quickly and reaches the final setting state in 7 minutes. The tricalcium silicate reaction is slower and usually takes more than 60 minutes to reach final setting.
当上述三个反应在这三元混合体系中同时发生时,反应(1),即生物活性玻璃颗粒表面释放出钙和硅离子将会大大加快反应(2)和反应(3)的速度,即加快水合硅酸钙凝胶相和二水硫酸钙晶相的形成。这两个新的相的形成,一方面占据颗粒间隙提高材料密度,另一方面同时形成的新的相与原生物活性玻璃颗粒、硅酸三钙颗粒以及半水硫酸钙颗粒交织在一起增加了材料强度。这样导致三元材料凝固加快,固化时间变短。这一特性使得三元系统具有更广泛的实用性。When the above three reactions occur simultaneously in the ternary mixed system, the reaction (1), that is, the release of calcium and silicon ions on the surface of the bioactive glass particles will greatly accelerate the speed of the reaction (2) and the reaction (3), that is, Accelerate the formation of the hydrated calcium silicate gel phase and the calcium sulfate dihydrate crystal phase. The formation of these two new phases, on the one hand, occupies the particle gap to increase the density of the material, on the other hand, the new phase formed at the same time is intertwined with the original bioactive glass particles, the tricalcium silicate particles and the calcium sulfate hemihydrate particles. Material strength. This causes the ternary material to solidify faster and the curing time becomes shorter. This feature makes the ternary system more widely applicable.
本发明所用的生物活性玻璃是组成为45S5的生物活性玻璃,是目前国际 常用的生物活性玻璃骨修复产品的组成。半水硫酸钙和硅酸三钙按中国专利申请号为200610029067.3的方法制备。三个成分均为100μm以下的颗粒。The bioactive glass used in the present invention is a bioactive glass having a composition of 45S5, which is currently international The composition of commonly used bioactive glass bone repair products. Calcium sulfate hemihydrate and tricalcium silicate are prepared according to the method of Chinese Patent Application No. 200610029067.3. The three components are all particles of 100 μm or less.
本发明的实验方法为将三种材料按不同比例以及生物活性玻璃按不同的颗粒尺寸进行充分混合,各混合物与调和液按液固质量比0.40-0.7ml/g的比例充分调和1分钟,即得到我们所述的可推注的膏剂。本发明所用的调和液为生理盐水、去离子水、无机盐(碳酸盐、氯化钙、磷酸盐等)溶液中的一种。The experimental method of the present invention is to thoroughly mix the three materials in different proportions and the bioactive glass according to different particle sizes, and each mixture and the solution are fully tempered for 1 minute at a liquid-solid mass ratio of 0.40-0.7 ml/g, that is, Get the pushable paste we have described. The solution used in the present invention is one of a solution of physiological saline, deionized water, inorganic salts (carbonate, calcium chloride, phosphate, etc.).
凝固时间是上述理想的骨水泥修复材料最关键的指标,在10分钟后20分钟内凝固最为理想。所以凝固实验的测试是优化组成最重要的步骤。考虑到在实际临床应用时,材料是在手术创面创口会有流血的存在,作为对比,材料凝固实验分别在空气和水中进行。在水中凝固实验时,混合物与调和液调好2分钟后将调配物放入水中观察测试凝固时间。水中的凝固更接近实际临床应用有流血存在的环境。The setting time is the most important indicator of the above-mentioned ideal bone cement repair material, and the solidification is ideal within 20 minutes after 10 minutes. Therefore, the test of the coagulation experiment is the most important step in optimizing the composition. Considering that in actual clinical applications, the material will have bleeding in the wound of the surgical wound. As a comparison, the material solidification experiments were carried out in air and water, respectively. In the water coagulation experiment, the mixture was adjusted to the conditioning solution for 2 minutes, and then the formulation was placed in water to observe the test setting time. The solidification in water is closer to the environment in which the actual clinical application has bleeding.
凝固时间实验测试方法按ISO9597-1989E国际标准,采用维卡仪(Vicat)针对上述骨水泥糊状膏剂物的初凝时间(I)和终凝时间(F)进行测试。初凝时间定义为维卡仪针(280g,1.13mm)垂直落下到装在小管中的膏剂时穿透深度为5±1mm所需要的时间;终凝时间定义为维卡仪针(350g,2.0mm)垂直落下到装在小管中的膏剂时在表面看不到明显印记所需要的时间。Coagulation time experimental test method According to the international standard of ISO9597-1989E, the initial setting time (I) and the final setting time (F) of the above-mentioned bone cement paste paste were tested by Vicat instrument. The initial setting time is defined as the time required for the Vicat instrument needle (280g, 1.13mm) to fall vertically to the paste contained in the small tube at a depth of 5 ± 1mm; the final setting time is defined as the Vicat needle (350g, 2.0) Mm) The time required for the mark to be placed in the small tube to be invisible on the surface.
(1)原材料单独凝固特性测试(1) Raw material individual solidification characteristics test
调和液为去离子水,调和比为1g:0.5ml,凝固条件在空气中:The blending solution is deionized water, the blending ratio is 1g: 0.5ml, and the solidification condition is in the air:
Figure PCTCN2017076980-appb-000001
Figure PCTCN2017076980-appb-000001
调和液为去离子水,凝固条件在水溶液中: The blending solution is deionized water and the solidification conditions are in an aqueous solution:
Figure PCTCN2017076980-appb-000002
Figure PCTCN2017076980-appb-000002
(2)三元系统的凝固时间测试(2) Solidification time test of ternary system
调和液为去离子水,凝固条件在空气中:The blending solution is deionized water and the solidification conditions are in the air:
Figure PCTCN2017076980-appb-000003
Figure PCTCN2017076980-appb-000003
调和液为去离子水,凝固条件在水溶液中:The blending solution is deionized water and the solidification conditions are in an aqueous solution:
Figure PCTCN2017076980-appb-000004
Figure PCTCN2017076980-appb-000004
调和液为CaCl2无机盐溶液,凝固条件在水溶液中:The blending solution is a CaCl 2 inorganic salt solution, and the solidification conditions are in an aqueous solution:
Figure PCTCN2017076980-appb-000005
Figure PCTCN2017076980-appb-000005
凝固实验结果:Solidification experiment results:
实验表明,半水硫酸钙对减少凝固时间起到主要作用。生物活性玻璃大颗粒的加入对系统凝固时间没有多大的改进,而小颗粒(<50μm)的加入对三元系统的凝固起到了促进作用。主要原因是小颗粒比表面积大,表面反应快,起 到促进凝固的作用。根据上述结果可以发现序号18、19、21是同一组成,无论是用水或无机盐溶液CaCl2调和还是在空气中或者水中环境凝,固其凝固特性呈现出较理想的实用性。Experiments have shown that calcium sulfate hemihydrate plays a major role in reducing the setting time. The addition of large particles of bioactive glass did not improve the solidification time of the system, and the addition of small particles (<50 μm) promoted the solidification of the ternary system. The main reason is that the small particles have a large specific surface area and a fast surface reaction, which promotes the solidification. According to the above results, it can be found that the serial numbers 18, 19, and 21 are the same composition, and whether it is conditioned with water or an inorganic salt solution of CaCl 2 or condensed in air or water, the solidification property of the solid exhibits an ideal practicability.
实施例一:Embodiment 1:
序号为18号的自固化可降解的生物活性膏剂骨修复材料的推注和凝固实验测试:Bolus and coagulation test of self-curing degradable bioactive ointment bone repair material No. 18:
称取18号组成混合物3克,称量1.5ml去离子水与混合物调拌混合60秒(调和比0.5ml/g)得到膏剂样品。推注性实验测试方法为将样品灌入15mL容量的带有喷嘴内径(D)为2.0mm针头的注射器,对其注射性进行试验。膏剂可从针筒中推注出,如图1所示。3 g of the composition mixture No. 18 was weighed, and 1.5 ml of deionized water was weighed and mixed with the mixture for 60 seconds (harmonization ratio of 0.5 ml/g) to obtain a paste sample. The bolus experimental test method was to inject the sample into a 15 mL-capacity syringe with a nozzle inner diameter (D) of 2.0 mm and test its injectability. The paste can be pushed out of the syringe as shown in Figure 1.
推出膏剂到:6-mm直径×6-mm高度的模具中进行凝固时间测试。凝固时间实验测试方法按ISO9597-1989E国际标准,采用维卡仪对上述膏剂物的初凝时间(I)和终凝时间(F)进行测试。测试3个样品。下表为测试结果:The paste was introduced into a mold of 6-mm diameter x 6-mm height for the setting time. Coagulation time experimental test method According to the international standard of ISO9597-1989E, the initial setting time (I) and the final setting time (F) of the above paste were tested by using a Vicat instrument. Test 3 samples. The following table shows the test results:
Figure PCTCN2017076980-appb-000006
Figure PCTCN2017076980-appb-000006
实施例二:Embodiment 2:
序号为18号的自固化可降解的生物活性膏剂骨修复材料的生物活性测试:Bioactivity test of self-curing degradable bioactive ointment bone repair material No. 18:
生物活性测试方法:自固化生物活性材料按配比调和,调和液为去离子水,调和比0.5ml/g,调和时间60秒。调成的膏剂再用模具:6-mm直径×2-mm高度,凝固成圆片。样品数量3个。浸泡SBF时按照样品表面积/溶液体积=0.1cm-1将圆片分别悬挂在SBF中,在37°的环境中反应。反应为1天、3天和7天。反应样品进行FTIR红外反射谱进行表面测试。反射峰574cm-1和608cm-1的出现 将表明羟基磷灰石的形成,即表明材料具有生物活性。检测结果见图2。Biological activity test method: self-curing bioactive material is blended according to the ratio, the blending solution is deionized water, the blending ratio is 0.5 ml/g, and the blending time is 60 seconds. The prepared paste is then used in a mold: 6-mm diameter x 2-mm height, and solidified into a wafer. The number of samples is 3. When the SBF was soaked, the wafers were suspended in SBF according to the sample surface area/solution volume = 0.1 cm -1 , and reacted in an environment of 37 °. The reaction was 1 day, 3 days and 7 days. The reaction samples were subjected to FTIR infrared reflectance spectroscopy for surface testing. The appearance of the reflection peaks of 574 cm -1 and 608 cm -1 will indicate the formation of hydroxyapatite, indicating that the material is biologically active. The test results are shown in Figure 2.
实施例三:Embodiment 3:
序号为18号的自固化可降解的生物活性膏剂骨修复材料的抗压强度测试:Compressive strength test of self-curing degradable bioactive paste bone repair material No. 18:
力学抗压强度测试方法:新型自固化生物活性产品样品通过SBF拟人体溶液浸泡反应不同时间来测定抗压强度变化。自固化生物活性材料按配比调和,调和液为去离子水,调和比0.5ml/g,调和时间60秒。调成的膏剂再用模具:6-mm直径×12-mm高度,凝固成圆柱。样品数量30个。浸泡SBF时,每天换液,按照样品表面积/溶液体积=0.1cm-1将圆柱分别悬挂在SBF中,在37°的环境中反应。反应为6个时间点,每个时间点为一组,样品分6组,每组测试5个样品。6个时间点为:1小时、2小时、8小时、1天、3天和7天。将每组测试结果进行统计取平均值并计算出正负差,抗压强度随反应时间变化结果如下表和图3所示。Mechanical compressive strength test method: The new self-curing bioactive product sample is determined by SBF quasi-human solution soaking reaction for different time to determine the compressive strength change. The self-curing bioactive material is blended according to the ratio, the blending solution is deionized water, the blending ratio is 0.5 ml/g, and the blending time is 60 seconds. The prepared paste is then used in a mold: 6-mm diameter x 12-mm height, and solidified into a cylinder. The number of samples is 30. When soaking the SBF, change the liquid every day, and suspend the cylinders in the SBF according to the sample surface area/solution volume = 0.1 cm -1 and react in an environment of 37 °. The reaction was at 6 time points, each time point was a group, the samples were divided into 6 groups, and 5 samples were tested in each group. The six time points are: 1 hour, 2 hours, 8 hours, 1 day, 3 days, and 7 days. The statistical results of each set of test results were averaged and the positive and negative differences were calculated. The results of compressive strength as a function of reaction time are shown in the following table and in Figure 3.
Figure PCTCN2017076980-appb-000007
Figure PCTCN2017076980-appb-000007
Figure PCTCN2017076980-appb-000008
Figure PCTCN2017076980-appb-000008
实施例四:Embodiment 4:
序号为18号的自固化可降解的生物活性膏剂骨修复材料的动物实验:Animal experiment with self-curing degradable bioactive paste bone repair material No. 18:
动物实验用新西兰白兔2-3公斤。缺损模型为股骨远端(distal femur condyle)髁骨,6mm×10mm,如图4所示。植入3个月后的组织学观察,如图5所示。图5显示了18号膏体植入兔髁骨缺损3个月后的情况组织学情况。从图片来看,材料大体上保持了其形状特点(植入体为圆柱状块体),材料内部未见明显裂纹,材料表面未见明显颗粒剥落,材料边缘为白色,表面活性反应所致形成的多孔相表明溶解吸收反应开始。说明材料降解方式可能主要是由外向内溶解吸收。在染色过程中发现材料内部会被染成蓝色,乙醇未冲洗掉。对材料表面进行观察可以发现明显的新骨形成,图6为材料植入后骨结合率即材料与骨组织形成骨性结合的面积百分比。这表明材料表面和骨组织呈现良好的骨性结合。通常的生物活性骨修复材料在3个月时会出现明显降解。本发明的最佳组成18号在3个月时表面出现降解但材料基本上保持其形状,表明非常缓慢的降解速度。这是本发明所需要的可凝固能承受负荷力又具有生物活性的膏剂,会缓慢降解,引导骨组织形成,最后由本体骨组织取代,为最理想骨修复产品。New Zealand white rabbits used 2-3 kg for animal experiments. The defect model was the distal femur condyle tibia, 6 mm x 10 mm, as shown in Figure 4. Histological observations after 3 months of implantation are shown in Figure 5. Figure 5 shows the histology of the 18th paste implanted into the rabbit's tibia defect 3 months later. From the picture, the material generally retains its shape characteristics (the implant is a cylindrical block), there is no obvious crack inside the material, no obvious particle peeling on the surface of the material, the material edge is white, and the surface active reaction is formed. The porous phase indicates the start of the dissolution absorption reaction. It indicates that the degradation mode of the material may be mainly absorbed by the outward inward dissolution. During the dyeing process, it was found that the inside of the material was dyed blue and the ethanol was not washed away. Observing the surface of the material revealed significant new bone formation. Figure 6 shows the percentage of the bone binding rate after material implantation, that is, the area where the material forms bone binding with the bone tissue. This indicates that the material surface and bone tissue exhibit a good bone bond. The usual bioactive bone repair materials show significant degradation at 3 months. The optimum composition of the present invention No. 18 showed degradation on the surface at 3 months but the material substantially retained its shape, indicating a very slow rate of degradation. This is a paste which can be solidified and can bear the load and is biologically active, which will slowly degrade, guide the formation of bone tissue, and finally be replaced by the body bone tissue, which is the most ideal bone repair product.
本发明公开的一种由生物活性玻璃-半水硫酸钙-硅酸三钙三元系统形成的可推注自固化可降解的生物活性膏剂骨修复材料,可替代现常用的惰性骨水泥而用于骨科椎体成型手术、膝髋关节置换手术以及其它骨折缺损填充手术中。这一新一代骨水泥修复材料能在合理的时间内凝固逐渐建立起一定的力学强度。特别重要的是这一新一代骨水泥修复材料由于引入生物活性玻璃而加快了凝固时间,增强了生物活性及骨传导性以及缓慢降解性。缓慢降解的同时,材料由生物活性及骨传导性会引导本体骨生长,最终,在骨水泥修复材料完全降 解时,由生长的本体骨完全取而代之。另一特别重要的是这一新一代骨水泥修复材料与其它传统的骨水泥不同,可直接与抗菌素如庆大霉素液体调和,对凝固时间和力学强度无明显影响。将抗菌素引入体系中而缓释,以防止手术缺损伤口处的感染。The invention discloses a pushable self-curing degradable bioactive paste bone repairing material formed by a bioactive glass-calcium sulfate hemihydrate-tricalcium silicate ternary system, which can be used instead of the commonly used inert bone cement. For orthopedic vertebral body surgery, knee and hip replacement surgery and other fracture defect filling operations. This new generation of bone cement repair material can establish a certain mechanical strength by solidification in a reasonable time. Of particular importance is the fact that this new generation of bone cement repair materials accelerates clotting time due to the introduction of bioactive glass, enhancing bioactivity and osteoconductivity as well as slow degradation. At the same time of slow degradation, the material will guide the growth of the body bone by biological activity and osteoconductivity, and finally, the bone cement repair material will drop completely. When the solution is solved, it is completely replaced by the growing body bone. Another important point is that this new generation of bone cement repair material, unlike other traditional bone cements, can be directly blended with antibiotics such as gentamicin liquid, with no significant effect on solidification time and mechanical strength. The antibiotic is introduced into the system for sustained release to prevent infection at the wound site.
本发明的发明人之一曾专利报道了用半水硫酸钙/硅酸三钙两元系统复合自固化生物活性材料、制备方法及其应用,具体的申请号为200610029067.3和200810204780.6。为了研制出更为理想的骨水泥修复材料,本发明引入生物活性最强成骨性最快已在临床上成功应用20多年的组成代号为45S5的生物活性玻璃,使之成为一个生物活性玻璃-半水硫酸钙-硅酸三钙三元系统。由于微米生物活性玻璃颗粒的引入,将会使得新的材料凝固时间具有实用性,降解速率得到改善,生物相容性和成骨性得到提高。得到更理想的可推注自固化可吸收的膏剂骨水泥修复材料,作为骨修复替代材料能用于椎体成型手术、膝髋关节置换手术以及其它一些骨折手术中。One of the inventors of the present invention has reported a self-curing bioactive material composited with a calcium sulfate hemihydrate/tricalcium silicate system, a preparation method thereof, and its application, and the specific application numbers are 200610029067.3 and 200810204780.6. In order to develop a more ideal bone cement repairing material, the present invention introduces the bioactive glass with the most biologically active osteogenicity and has been successfully applied for more than 20 years in clinical practice, which is coded as 45S5, making it a bioactive glass- Calcium sulfate hemihydrate - tricalcium silicate ternary system. Due to the introduction of micron bioactive glass particles, the new material solidification time will be practical, the degradation rate will be improved, and the biocompatibility and osteogenic properties will be improved. A more desirable self-curing self-cure absorbable plaster cement repair material can be used as an alternative to bone repair for vertebral body shaping surgery, knee hip replacement surgery, and other fracture operations.
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。 The above is only the embodiment of the present invention, and thus does not limit the scope of the patent of the present invention. Any equivalent structure or equivalent process transformation made by using the contents of the specification of the present invention, or directly or indirectly applied to other related technical fields, The same is included in the scope of patent protection of the present invention.

Claims (10)

  1. 一种自固化可降解的生物活性膏剂骨修复材料,其特征在于,包括混合固体材料和液相,所述混合固体材料包括生物活性玻璃、半水硫酸钙和硅酸三钙,所述液相包括调和液。A self-curing degradable bioactive paste bone repairing material, comprising: a mixed solid material comprising a bioactive glass, calcium sulphate hemihydrate and tricalcium silicate, said liquid phase Includes blending fluid.
  2. 根据权利要求1所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述混合固体材料的组成包括:以重量百分比计,生物活性玻璃15%-30%、半水硫酸钙30%-45%、硅酸三钙30%-40%;所述混合固体材料与所述液相的调和比为1g:0.3ml-1g:0.8ml;所述生物活性玻璃的粒径小于等于100μm,所述半水硫酸钙的粒径小于等于100μm,所述硅酸三钙的粒径小于等于100μm。The self-cure degradable bioactive paste bone repair material according to claim 1, wherein the composition of the mixed solid material comprises: 15%-30% by weight of bioactive glass, calcium sulfate hemihydrate 30%-45%, tricalcium silicate 30%-40%; the mixing ratio of the mixed solid material to the liquid phase is 1g: 0.3ml-1g: 0.8ml; the particle size of the bioactive glass is less than or equal to 100 μm, the particle size of the calcium sulfate hemihydrate is 100 μm or less, and the particle size of the tricalcium silicate is 100 μm or less.
  3. 根据权利要求2所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述混合固体材料的组成包括:以重量百分比计,生物活性玻璃27%、半水硫酸钙41.5%、硅酸三钙31.5%;所述混合固体材料与所述液相的调和比为1g:0.5ml。The self-cure degradable bioactive paste bone repair material according to claim 2, wherein the composition of the mixed solid material comprises: 27% by weight of biologically active glass, 41.5% of calcium sulfate hemihydrate, Tricalcium silicate 31.5%; the blending ratio of the mixed solid material to the liquid phase is 1 g: 0.5 ml.
  4. 根据权利要求1-3任一所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述生物活性玻璃是组成为45S5的生物活性玻璃。The self-curing degradable bioactive paste bone repair material according to any one of claims 1 to 3, wherein the bioactive glass is a bioactive glass having a composition of 45S5.
  5. 根据权利要求1-3任一所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述调和液为生理盐水、去离子水、无机盐溶液中的一种或多种。The self-cure degradable bioactive paste bone repair material according to any one of claims 1 to 3, wherein the solution is one or more of physiological saline, deionized water, and inorganic salt solution.
  6. 根据权利要求5所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述无机盐溶液为碳酸盐溶液、氯化钙溶液、磷酸盐溶液中的一种或多种。The self-cure degradable bioactive paste bone repair material according to claim 5, wherein the inorganic salt solution is one or more of a carbonate solution, a calcium chloride solution, and a phosphate solution.
  7. 根据权利要求1所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述自固化可降解的生物活性膏剂骨修复材料的凝固时间为10-20分钟;所述自固化可降解的生物活性膏剂骨修复材料在生物环境中的力学强度是逐渐增强的;所述自固化可降解的生物活性膏剂骨修复材料具有缓慢降解性。The self-cure degradable bioactive paste bone repairing material according to claim 1, wherein the self-curing biodegradable bioactive plaster bone repairing material has a setting time of 10-20 minutes; The mechanical strength of the degraded bioactive paste bone repair material in the biological environment is gradually enhanced; the self-cure degradable bioactive paste bone repair material has a slow degradability.
  8. 根据权利要求1所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述自固化可降解的生物活性膏剂骨修复材料在骨缺损填充手术中进行应用。The self-cure degradable bioactive paste bone repair material according to claim 1, wherein the self-curing degradable bioactive plaster bone repair material is applied in a bone defect filling operation.
  9. 根据权利要求8所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述自固化可降解的生物活性膏剂骨修复材料在骨科椎体成型手术、膝髋关节置换手术中进行应用。The self-cure degradable bioactive paste bone repair material according to claim 8, wherein the self-cure degradable bioactive paste bone repair material is performed in orthopedic vertebral body shaping surgery and knee hip joint replacement surgery. application.
  10. 根据权利要求1所述的自固化可降解的生物活性膏剂骨修复材料,其特征在于,所述自固化可降解的生物活性膏剂骨修复材料在使用时能直接与抗菌素调和,同时保持了药效性又不影响凝固时间和强度;优选地,所述抗菌素为庆大霉素液体。 The self-cure degradable bioactive paste bone repair material according to claim 1, wherein the self-cure degradable bioactive paste bone repair material can directly reconcile with the antibiotic when used, while maintaining the efficacy The nature does not affect the setting time and strength; preferably, the antibiotic is a gentamicin liquid.
PCT/CN2017/076980 2016-07-05 2017-03-16 Self-hardening degradable bioactive bone repair material paste and use thereof WO2018006618A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610521638.9A CN106075565B (en) 2016-07-05 2016-07-05 Self-curing degradable biological active paste bone renovating material and application
CN201610521638.9 2016-07-05

Publications (1)

Publication Number Publication Date
WO2018006618A1 true WO2018006618A1 (en) 2018-01-11

Family

ID=57213018

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/076980 WO2018006618A1 (en) 2016-07-05 2017-03-16 Self-hardening degradable bioactive bone repair material paste and use thereof

Country Status (3)

Country Link
CN (1) CN106075565B (en)
TW (1) TWI587881B (en)
WO (1) WO2018006618A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106075565B (en) * 2016-07-05 2019-02-15 盐城倍尔生生物科技有限公司 Self-curing degradable biological active paste bone renovating material and application
CN109133971B (en) * 2018-09-30 2021-05-25 广州润虹医药科技股份有限公司 Calcium phosphate/bioactive glass bone repair scaffold and preparation method thereof
CN110237299A (en) * 2019-06-25 2019-09-17 太仓新亚逊生物科技有限公司 Degradation-type bone renovating material
CN112791233B (en) * 2020-12-29 2022-04-05 同济大学 Biological glass composite bone cement and electric field treatment method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1911458A (en) * 2006-07-18 2007-02-14 中国科学院上海硅酸盐研究所 Bio-activity tricalcium silicate/semi water calcium sulphate composite self-solidification material, preparation and application
CN1923302A (en) * 2006-07-18 2007-03-07 中国科学院上海硅酸盐研究所 Calcium sulfate semihydrate group combined self-curing bio-active material, preparation and application thereof
US20080221701A1 (en) * 2007-03-09 2008-09-11 Jipin Zhong Osteostimulative settable bone graft putty
US7942961B2 (en) * 2007-02-22 2011-05-17 Saeed Asgary Endodontic filling material
US20130059013A1 (en) * 2010-05-13 2013-03-07 Politecnico Di Torino Injectable osteoinductive bone cements
CN103143063A (en) * 2013-01-28 2013-06-12 中国人民解放军第四军医大学 Composite biological material capable of injecting bioglass-calcium phosphate bone cement and preparation
CN106075565A (en) * 2016-07-05 2016-11-09 盐城倍尔生生物科技有限公司 Self-curing degradable biological active paste bone renovating material and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2142225B1 (en) * 2007-04-20 2014-12-17 Innovative Bioceramix, INC. Premixed biological hydraulic cement paste composition and using the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1911458A (en) * 2006-07-18 2007-02-14 中国科学院上海硅酸盐研究所 Bio-activity tricalcium silicate/semi water calcium sulphate composite self-solidification material, preparation and application
CN1923302A (en) * 2006-07-18 2007-03-07 中国科学院上海硅酸盐研究所 Calcium sulfate semihydrate group combined self-curing bio-active material, preparation and application thereof
US7942961B2 (en) * 2007-02-22 2011-05-17 Saeed Asgary Endodontic filling material
US20080221701A1 (en) * 2007-03-09 2008-09-11 Jipin Zhong Osteostimulative settable bone graft putty
US20130059013A1 (en) * 2010-05-13 2013-03-07 Politecnico Di Torino Injectable osteoinductive bone cements
CN103143063A (en) * 2013-01-28 2013-06-12 中国人民解放军第四军医大学 Composite biological material capable of injecting bioglass-calcium phosphate bone cement and preparation
CN106075565A (en) * 2016-07-05 2016-11-09 盐城倍尔生生物科技有限公司 Self-curing degradable biological active paste bone renovating material and application

Also Published As

Publication number Publication date
CN106075565B (en) 2019-02-15
TW201801756A (en) 2018-01-16
CN106075565A (en) 2016-11-09
TWI587881B (en) 2017-06-21

Similar Documents

Publication Publication Date Title
JP5646849B2 (en) Apatite-type calcium phosphate cement with macroporosity and high absorbency
ES2535006T3 (en) Composition of ready-mixed biological hydraulic cement paste and use thereof
CA2487994C (en) Hydraulic cement based on calcium phosphate for surgical use
Dorozhkin Calcium orthophosphate cements for biomedical application
Fada et al. Mechanical properties improvement and bone regeneration of calcium phosphate bone cement, Polymethyl methacrylate and glass ionomer
Ambrosio et al. Injectable calcium-phosphate-based composites for skeletal bone treatments
WO2018006618A1 (en) Self-hardening degradable bioactive bone repair material paste and use thereof
JP2003513711A (en) Resorbable bone implant material and method for producing the same
KR20110000636A (en) Bone graft material and uses thereof
Grandi et al. Comparative histomorphometric analysis between α-Tcp cement and β-Tcp/Ha granules in the bone repair of rat calvaria
Vezenkova et al. Sudoku of porous, injectable calcium phosphate cements–Path to osteoinductivity
SE524334C2 (en) Heat-generating biocompatible ceramic materials and processes for their preparation
CN109395160B (en) Rapidly degradable injectable bone cement and application thereof
EP2077126A1 (en) Analgesic apatitic calcium-phosphate cement
Ozdemir et al. Calcium phosphate cements for medical applications
TWI805355B (en) Moldable orthopedic composition with anti-washout property
WO2023216069A1 (en) Plastic orthopedic composition having erosion resistance
CN115554468B (en) Bone cement containing bioactive glass and preparation method and application thereof
CN117065088A (en) Plastic orthopedic composition with anti-scour capability
CN115645622A (en) Bone cement composition and method for preparing same
Wu Development of biocomposite scaffolds and injectable biocement for bone regeneration.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17823431

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17823431

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17823431

Country of ref document: EP

Kind code of ref document: A1